Understanding Wegovy vs Mounjaro Dosing Differences
Wegovy vs Mounjaro Doses: UK Stock Availability Analysis
When comparing Wegovy vs Mounjaro doses, availability has historically been a crucial factor for UK patients. Wegovy experienced significant supply constraints throughout 2022-2023, whilst Mounjaro faced initial shortages following its UK launch. At EverydayMeds, we've established robust supply chains with both Novo Nordisk and Eli Lilly to ensure consistent stock levels across all dose strengths. Our pharmacy maintains full inventory of Wegovy's five-dose escalation schedule (0.25mg through 2.4mg) alongside Mounjaro's four-dose progression (2.5mg through 15mg maintenance).
The key difference in Wegovy vs Mounjaro doses lies in their escalation timelines and mechanisms. Wegovy follows a 16-week dose escalation over five strengths, whilst Mounjaro uses a 12-week escalation over four strengths. Both require gradual dose increases to minimise gastrointestinal side effects, but Mounjaro's faster escalation suits patients seeking quicker progression to maintenance doses. Our clinical team can guide you through either dosing schedule based on your individual tolerance and treatment goals.
Wegovy vs Mounjaro Doses: Pricing and Bundle Options
Understanding the cost implications of Wegovy vs Mounjaro doses helps inform treatment decisions over the long term. Wegovy single pens range from £79.99 (0.25mg starter) to £209.99 (2.4mg maintenance), whilst Mounjaro pricing follows a similar structure with different dose equivalencies. Our Getting Started bundles, such as the Intro Duo (0.25mg & 0.5mg Wegovy for £169.99), provide convenient dose progression without multiple orders. New customers can apply code FIRST40 at checkout, whilst returning patients use code DOSE25 for optimal pricing.
The economic consideration of Wegovy vs Mounjaro doses extends beyond initial costs to long-term maintenance requirements. Wegovy's 2.4mg maintenance dose costs £209.99 monthly, whilst some patients may find Mounjaro's dosing structure better suits their budget planning. Our Ultimate Stability Trio provides three months of Wegovy 2.4mg maintenance supply for £649.99, offering supply security alongside convenience. Both medications require ongoing prescription-only medicine oversight, ensuring safe and effective long-term weight management support.
Clinical Evidence Comparing Wegovy vs Mounjaro Doses
The clinical evidence base for Wegovy vs Mounjaro doses derives from separate trial programmes with different patient populations and endpoints. Wegovy's STEP trials demonstrated that patients taking the medication alongside diet and exercise achieved average weight reductions of approximately 15% at 68 weeks (Wilding et al., NEJM, 2021). The dose escalation protocol in STEP trials followed the current UK-licensed schedule from 0.25mg through 2.4mg maintenance.
Mounjaro's SURMOUNT trials evaluated the tirzepatide dose progression through 2.5mg, 5mg, 10mg, and 15mg strengths, showing different efficacy profiles at various dose levels. When considering Wegovy vs Mounjaro doses, it's important to note that direct head-to-head comparisons aren't available due to different trial designs and patient populations. Both medications have demonstrated cardiovascular benefits in their respective clinical programmes, supporting their roles in comprehensive weight management strategies.
How Wegovy Works: GLP-1 Mechanism Explained
Understanding Wegovy's mechanism helps clarify how its dosing schedule supports weight management outcomes. As a GLP-1 receptor agonist, Wegovy mimics the natural incretin hormone GLP-1, which regulates appetite and satiety signals in the brain. The medication slows gastric emptying, promoting feelings of fullness after smaller meals, whilst reducing food cravings through direct effects on hypothalamic appetite centres. Each weekly injection maintains steady semaglutide levels, providing consistent appetite regulation throughout the seven-day dosing interval. The gradual dose escalation from 0.25mg to 2.4mg allows patients to adapt to these metabolic changes whilst minimising potential side effects. This mechanism differs from Mounjaro's dual GIP+GLP-1 receptor approach, offering patients distinct treatment options based on their physiological responses.
Ordering Process for Wegovy vs Mounjaro Doses
Accessing either medication through EverydayMeds follows our streamlined prescription-only medicine pathway designed for busy patients. The process begins with a comprehensive 3-minute online clinical assessment covering medical history, current medications, and weight management goals relevant to your chosen treatment. Our qualified prescribers review each application within 3 working days (or 24 hours with express service), ensuring appropriate patient selection for either Wegovy or Mounjaro dosing protocols. Once approved, your medication ships via next-day delivery using specialist cold-chain logistics to maintain the 2-8°C temperature requirements. Our GPhC-registered pharmacy (#9012878) handles all aspects of dispensing, packaging, and temperature-controlled transport. Payment is secured at checkout using your selected discount code, with full treatment information and injection guidance included in every delivery.
Storage Advantages: Wegovy vs Mounjaro Doses
Practical storage considerations can influence the choice between Wegovy vs Mounjaro doses, particularly for patients with active lifestyles or frequent travel commitments. Wegovy offers superior room temperature stability, remaining effective for up to 6 weeks when stored below 30°C after removal from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require initial refrigerated storage at 2-8°C and use similar pen injection devices for weekly administration. The FlexTouch pen system used for Wegovy doses provides clear dose selection and injection feedback, whilst Mounjaro uses KwikPen technology with comparable usability. Patients progressing through either dose escalation schedule should rotate injection sites across abdomen, thigh, or upper arm locations. The extended room temperature stability of Wegovy doses provides additional flexibility for patients managing complex schedules or extended periods away from refrigeration facilities.
Supply Chain Security for Wegovy vs Mounjaro Doses UK
The reliability of Wegovy vs Mounjaro doses supply represents a critical factor for patients committing to long-term weight management treatment. EverydayMeds has invested significantly in robust pharmaceutical supply relationships with both Novo Nordisk and Eli Lilly, ensuring consistent stock availability across all dose strengths. Our inventory management systems track real-time stock levels and automatically reorder based on demand forecasting, preventing the supply interruptions that affected other UK pharmacies during 2023.
Unlike some competitors who struggled with intermittent Wegovy availability, our direct manufacturer relationships ensure priority allocation during high-demand periods. We maintain strategic stock reserves of popular doses, including the 0.25mg starter and 2.4mg maintenance strengths that frequently experience supply pressure elsewhere. This supply security means patients can confidently begin treatment knowing their dose progression won't be interrupted by availability issues.
Order Your Wegovy vs Mounjaro Doses Today
Making an informed decision between Wegovy vs Mounjaro doses becomes straightforward when both options remain consistently available through our secure supply chains. Whether you're drawn to Wegovy's proven GLP-1 mechanism and extended room temperature stability, or considering Mounjaro's dual-receptor approach, our clinical team can guide you towards the most appropriate choice. New customers should apply code FIRST40 at checkout for optimal pricing, whilst returning patients can use code DOSE25 for continued savings. Begin your clinical assessment today at https://everydaymeds.co.uk/collections/wegovy and take the first step towards medically-supported weight management. Our next-day delivery service ensures you can start treatment immediately once prescribed, with ongoing clinical support throughout your dose escalation journey. Both medications are available for immediate dispatch, eliminating the uncertainty that has affected UK patients seeking reliable access to these prescription-only medicines.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
